Independent lab tested
HPLC-verified purity
UK & EU dispatch
Free next day delivery
Independent lab tested
HPLC-verified purity
UK & EU dispatch
Free next day delivery
Quality, on the record

You should not have to take purity on faith.

Every product in the Vialoxa catalogue has undergone independent testing - identity by mass spectrometry and purity by reverse-phase HPLC.

99.2%
Median purity
100%
Products independently tested
LC-MS
Identity confirmation
24h
Typical dispatch
Anatomy of a certificate

What is actually on the paperwork.

Certificates shown here explain the identity checks, measured purity and specification used in independent product testing. They are provided as representative product documentation.

  • Purity is not identity

    A high HPLC figure only tells you the main peak is dominant. Mass spectrometry confirms whether that peak is the sequence on the label, so our product testing uses both methods.

  • Net peptide content matters

    Lyophilised material carries counter-ions and residual moisture. Net peptide content tells you how much peptide is actually in the vial, so your dosing maths holds from vial to vial.

  • Representative documentation

    Certificates shown on our site document independent product testing and are provided as representative documentation for each product.

Vialoxa Research
Certificate of analysis
Lot
VLX-2418
Product
Semaglutide (reference standard)
Appearance
White lyophilised powder
Storage
−20 °C · protect from light
TestSpecificationResult
HPLC purity≥ 99.0%99.4%
Mass-spec identityConformsConfirmed
Net peptide contentReport92.7%
Moisture (Karl Fischer)< 5.0%3.1%
AppearanceWhite lyophilised cakeConforms
HPLC chromatogram and mass spectrometry readout beside a sealed reference vial
Quality control · released 2026
Verified
The protocol

Six steps in our quality process.

Our products follow a defined sourcing, testing, filling and release process, with independent test results verifying every product.

01
Synthesis

Solid-phase peptide synthesis under controlled conditions with vetted UK and EU partners, then cleaved and purified to specification.

02
Purification

Preparative reverse-phase HPLC removes truncated and deletion sequences until the lot meets our release specification.

03
Identity confirmation

Molecular mass is confirmed by MALDI-TOF or ESI mass spectrometry against the theoretical mass for the sequence.

04
Purity quantification

Analytical reverse-phase HPLC quantifies product purity and reports the figure to one decimal place.

05
Fill & finish

Lyophilised, filled under inert atmosphere into borosilicate vials, crimp-sealed and protected from light.

06
Release & dispatch

Products are released to specification and dispatched from the UK or EU, typically within 24 hours.

Macro photograph of a lyophilised peptide cake inside a sealed glass vial
Storage & handling

Protect the material after delivery.

Unopened vials

Store at −20 °C, desiccated and protected from light. Follow the storage guidance shown on the product page.

In transit

Lyophilised material tolerates ambient transit; refrigerate on arrival and freeze for long-term storage.

After reconstitution

Handle under aseptic laboratory conditions. Reconstituted material has a materially shorter working life.

Documentation

Keep the product page and representative testing documentation with your laboratory records.

Rack of sealed research reference vials
Sealed under inert gas

Crimp-sealed and light-protected, vial by vial.

Analyst inspecting a reference vial in the laboratory
Characterised by analysts

Every product independently tested and documented.

Independent product testing, clearly explained.

Browse the catalogue of independently tested reference peptides. For laboratory research use only.

View the catalogue
Newsletter

Join the Vialoxa newsletter

Research updates, new catalogue arrivals and subscriber offers.

Research updates only. Unsubscribe at any time.